hrcak mascot   Srce   HID

Pregledni rad
https://doi.org/10.26800/LV-143-5-6-9

The role of non-alcoholic fatty liver disease in bacterial infections and sepsis

Juraj Krznarić ; Klinika za infektivne bolesti „Dr. Fran Mihaljević”, Zagreb
Maja Mijić ; Klinička bolnica Merkur, Zagreb
Ivana Štromar Knežević ; Klinički bolnički centar Zagreb, Zagreb; Medicinski fakultet, Sveučilište u Zagrebu, Zagreb
Dora Šuk ; Medicinski fakultet, Sveučilište u Zagrebu, Zagreb
Tajana Filipec Kanižaj ; Klinička bolnica Merkur, Zagreb; Medicinski fakultet, Sveučilište u Zagrebu, Zagreb
Adriana Vince ; Klinika za infektivne bolesti „Dr. Fran Mihaljević”, Zagreb; Medicinski fakultet, Sveučilište u Zagrebu, Zagreb
Neven Papić ; Klinika za infektivne bolesti „Dr. Fran Mihaljević”, Zagreb; Medicinski fakultet, Sveučilište u Zagrebu, Zagreb

Puni tekst: engleski, pdf (457 KB) str. 220-220 preuzimanja: 25* citiraj
APA 6th Edition
Krznarić, J., Mijić, M., Štromar Knežević, I., Šuk, D., Filipec Kanižaj, T., Vince, A. i Papić, N. (2021). The role of non-alcoholic fatty liver disease in bacterial infections and sepsis. Liječnički vjesnik, 143 (5-6), 220-220. https://doi.org/10.26800/LV-143-5-6-9
MLA 8th Edition
Krznarić, Juraj, et al. "The role of non-alcoholic fatty liver disease in bacterial infections and sepsis." Liječnički vjesnik, vol. 143, br. 5-6, 2021, str. 220-220. https://doi.org/10.26800/LV-143-5-6-9. Citirano 17.10.2021.
Chicago 17th Edition
Krznarić, Juraj, Maja Mijić, Ivana Štromar Knežević, Dora Šuk, Tajana Filipec Kanižaj, Adriana Vince i Neven Papić. "The role of non-alcoholic fatty liver disease in bacterial infections and sepsis." Liječnički vjesnik 143, br. 5-6 (2021): 220-220. https://doi.org/10.26800/LV-143-5-6-9
Harvard
Krznarić, J., et al. (2021). 'The role of non-alcoholic fatty liver disease in bacterial infections and sepsis', Liječnički vjesnik, 143(5-6), str. 220-220. https://doi.org/10.26800/LV-143-5-6-9
Vancouver
Krznarić J, Mijić M, Štromar Knežević I, Šuk D, Filipec Kanižaj T, Vince A i sur. The role of non-alcoholic fatty liver disease in bacterial infections and sepsis. Liječnički vjesnik [Internet]. 2021 [pristupljeno 17.10.2021.];143(5-6):220-220. https://doi.org/10.26800/LV-143-5-6-9
IEEE
J. Krznarić, et al., "The role of non-alcoholic fatty liver disease in bacterial infections and sepsis", Liječnički vjesnik, vol.143, br. 5-6, str. 220-220, 2021. [Online]. https://doi.org/10.26800/LV-143-5-6-9
Puni tekst: hrvatski, pdf (457 KB) str. 220-226 preuzimanja: 32* citiraj
APA 6th Edition
Krznarić, J., Mijić, M., Štromar Knežević, I., Šuk, D., Filipec Kanižaj, T., Vince, A. i Papić, N. (2021). Uloga nealkoholne masne bolesti jetre u bakterijskim infekcijama i sepsi. Liječnički vjesnik, 143 (5-6), 220-226. https://doi.org/10.26800/LV-143-5-6-9
MLA 8th Edition
Krznarić, Juraj, et al. "Uloga nealkoholne masne bolesti jetre u bakterijskim infekcijama i sepsi." Liječnički vjesnik, vol. 143, br. 5-6, 2021, str. 220-226. https://doi.org/10.26800/LV-143-5-6-9. Citirano 17.10.2021.
Chicago 17th Edition
Krznarić, Juraj, Maja Mijić, Ivana Štromar Knežević, Dora Šuk, Tajana Filipec Kanižaj, Adriana Vince i Neven Papić. "Uloga nealkoholne masne bolesti jetre u bakterijskim infekcijama i sepsi." Liječnički vjesnik 143, br. 5-6 (2021): 220-226. https://doi.org/10.26800/LV-143-5-6-9
Harvard
Krznarić, J., et al. (2021). 'Uloga nealkoholne masne bolesti jetre u bakterijskim infekcijama i sepsi', Liječnički vjesnik, 143(5-6), str. 220-226. https://doi.org/10.26800/LV-143-5-6-9
Vancouver
Krznarić J, Mijić M, Štromar Knežević I, Šuk D, Filipec Kanižaj T, Vince A i sur. Uloga nealkoholne masne bolesti jetre u bakterijskim infekcijama i sepsi. Liječnički vjesnik [Internet]. 2021 [pristupljeno 17.10.2021.];143(5-6):220-226. https://doi.org/10.26800/LV-143-5-6-9
IEEE
J. Krznarić, et al., "Uloga nealkoholne masne bolesti jetre u bakterijskim infekcijama i sepsi", Liječnički vjesnik, vol.143, br. 5-6, str. 220-226, 2021. [Online]. https://doi.org/10.26800/LV-143-5-6-9

Sažetak
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease associated with systemic changes in immune response that drives the progression to non-alcoholic steatohepatitis (NASH), liver cirrhosis, and hepatocellular carcinoma (HCC). Major risk factors of NAFLD include obesity and type 2 diabetes mellitus which are associated with infections. However, there is growing evidence that NAFLD is linked with bacterial infections independently of other components of metabolic syndrome. Patients with NAFLD have been described to have more common recurrent bacterial infections, urinary tract infections, bacteriemia of gastrointestinal origin, Clostridoides difficile enterocolitis, and more severe pneumonia. The rapidly increasing prevalence of NAFLD and NASH require novel therapeutic and prophylactic approaches based on a better understanding of immunopathogenesis of bacterial infections in these patients.

Ključne riječi
NON-ALCOHOLIC FATTY LIVER DISEASE – complications, epidemiology, immunology; LIVER – immunology; BACTERIAL INFECTIONS – epidemiology, etiology; SEPSIS – epidemiology, etiology

Hrčak ID: 260478

URI
https://hrcak.srce.hr/260478

[hrvatski]

Posjeta: 104 *